These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6171962)

  • 1. [Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
    Nemtsov AV; Kalinin VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1232-41. PubMed ID: 6171962
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 4. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
    Bartfai A; Levander SE; Sedvall G
    Biol Psychiatry; 1983 Sep; 18(9):971-87. PubMed ID: 6196060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemistry of withdrawal emergent symptoms in children.
    Winsberg BG; Hurwic MJ; Perel J
    Psychopharmacol Bull; 1977 Jul; 13(3):38-40. PubMed ID: 18757
    [No Abstract]   [Full Text] [Related]  

  • 7. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 8. Sleep variables, cyclic AMP and biogenic amine metabolites after one day of ethanol ingestion.
    Zarcone VP; Schreier L; Mitchell G; Orenberg E; Barchas J
    J Stud Alcohol; 1980 Mar; 41(3):318-24. PubMed ID: 6154831
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of response to neuroleptic drug therapy in schizophrenia.
    Awad AG
    Can J Psychiatry; 1985 Jun; 30(4):241-2. PubMed ID: 2861885
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of clozapine response in schizophrenia.
    Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 12. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
    Losonczy MF; Song IS; Mohs RC; Mathé AA; Davidson M; Davis BM; Davis KL
    Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 16. Low cerebrospinal fluid homovanillic acid-5-hydroxyindoleacetic acid ratio predicts clozapine efficacy: a replication.
    Risch SC; Lewine RR
    Arch Gen Psychiatry; 1993 Aug; 50(8):670. PubMed ID: 7688212
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
    Nisijima K; Oyafuso K; Shimada T; Hosino H; Ishiguro T
    Biol Psychiatry; 1996 Mar; 39(5):383-4. PubMed ID: 8704073
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Neuropsychobiology; 1982; 8(2):60-72. PubMed ID: 6175919
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 20. Simulated behavior states: an approach to specificity in psychobiological research.
    Post RM; Goodwin FK
    Biol Psychiatry; 1973 Dec; 7(3):237-54. PubMed ID: 4357567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.